MPS II

Clinical trials for MPS II explained in plain language.

Never miss a new study

Get alerted when new MPS II trials appear

Sign up with your email to follow new studies for MPS II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Hunterase shows continued safety in hunter syndrome patients

Disease control Completed

This study looked at the long-term safety and effectiveness of the drug Hunterase in people with Hunter syndrome. It included 30 patients who had already completed a previous study or had been using Hunterase for at least six months. Researchers monitored lab tests, physical exam…

Matched conditions: MPS II

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

MPS II

Get alerted when new MPS II trials appear

Hunterase shows continued safety in hunter syndrome patients